# Vicore Pharma Holding – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/vicore-pharma-holding
Company JSON: https://spela.port0.org/company/vicore-pharma-holding/company.json
Documents JSON: https://spela.port0.org/company/vicore-pharma-holding/documents.json
Updated: 2026-08-06T01:50:56Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/vicore-pharma-holding/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/vicore-pharma-holding/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/vicore-pharma-holding/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/vicore-pharma-holding/market/instrument.json
- SEC filing-manifest JSON: https://spela.port0.org/company/vicore-pharma-holding/market/sec-manifest.json
- SEC sammanfattning JSON: https://spela.port0.org/company/vicore-pharma-holding/market/sec-summary.json
- MFN manifest JSON: https://spela.port0.org/company/vicore-pharma-holding/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/vicore-pharma-holding/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/vicore-pharma-holding/reports
- JSON: https://spela.port0.org/company/vicore-pharma-holding/reports/reports.json
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=b00c6b9419fef5bc28396a5eea3441408&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=b600d68604b5fc3eac062c3954b408421&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b72784e8b83c8522ce08632a00a87ef39&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b7db3aa72a81418db70ff496c131bfcc0&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b97f6d13a90c2672b76c146ae640a80cb&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=b3054c17c4a86c0f5b08a02f0e9590b1e&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=bdd4d68888e865bc214adcdd4677b1d08&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=b360b480bb9fc49e165fd522b72bf1b42&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=ba1091d4997b1ad6a448ff25af01915e0&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=b8e0088e8cb4bbbc4bdd222a8d48f4385&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=b07abb63329fd21adf8d4a9f2ba0e3bb6&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=bd7b3e65ea8ded43a8959cfcf5981d5eb&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=b5cb03fd0542c64e01c883b37cd1f5acd&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b2c54299bcf62d6367d586a5c4588c58f&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=b9c1e213206b463347e49c17c1c83df25&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b135579da42267f8c35aef4506d1d7e46&lang=sv&src=listed

## Morningstar Institutions
- Page: https://spela.port0.org/company/vicore-pharma-holding/morningstar
- Summary: https://spela.port0.org/company/vicore-pharma-holding/morningstar/summary.txt
- Screenshot: https://spela.port0.org/company/vicore-pharma-holding/morningstar/screenshot.png

## Finansinspektionen
- Page: https://spela.port0.org/company/vicore-pharma-holding/finansinspektionen
- Summary: https://spela.port0.org/company/vicore-pharma-holding/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/vicore-pharma-holding/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/vicore-pharma-holding/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/vicore-pharma-holding/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/vicore-pharma-holding/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/vicore-pharma-holding/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- SEC EDGAR | SEC filing – odaterad – tm2619347d1_ex99-1.htm: https://spela.port0.org/company/vicore-pharma-holding/documents/sec-edgar-sec-filing-odaterad-tm2619347d1-ex99-1-htm/fulltext.txt
- SEC EDGAR | SEC filing – odaterad – tm2619347d1_6k.htm: https://spela.port0.org/company/vicore-pharma-holding/documents/sec-edgar-sec-filing-odaterad-tm2619347d1-6k-htm/fulltext.txt
- SEC EDGAR | SEC filing – odaterad – 0001104659-26-080617.txt: https://spela.port0.org/company/vicore-pharma-holding/documents/sec-edgar-sec-filing-odaterad-0001104659-26-080617-txt/fulltext.txt
- SEC EDGAR | SEC filing – odaterad – 0001104659-26-080617-index.html: https://spela.port0.org/company/vicore-pharma-holding/documents/sec-edgar-sec-filing-odaterad-0001104659-26-080617-index-html/fulltext.txt
- SEC EDGAR | SEC filing – odaterad – 0001104659-26-080617-index-headers.html: https://spela.port0.org/company/vicore-pharma-holding/documents/sec-edgar-sec-filing-odaterad-0001104659-26-080617-index-headers-html/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/vicore-pharma-holding/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt